Excedrin Migraine Relief 250 mg/1 (Acetaminophen, Aspirin (NSAID), Caffeine TABLET, FILM COATED) 250 mg/1

Excedrin Migraine Relief 250 mg/1 combines acetaminophen, aspirin, and caffeine for targeted migraine relief. This oral tablet is designed to alleviate migraine symptoms effectively.

Strength

250 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0067-2042-05) / 125 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

Haleon US Holdings LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Excedrin Migraine Relief 250 mg/1 is commonly used for migraine pain relief. It combines acetaminophen, aspirin, and caffeine to address migraine symptoms. People often seek this medication when looking for what is Excedrin used for, particularly for managing migraine headaches.

Side Effects

Excedrin Migraine Relief 250 mg/1 may cause common effects such as drowsiness, dizziness, or upset stomach. Some users report feeling more alert due to the caffeine content. Always follow the instructions on the label for safe use.

Precautions & Warnings

Handle Excedrin Migraine Relief 250 mg/1 with care, especially if you have allergies to acetaminophen, aspirin, or caffeine. Store in a cool, dry place away from children. Consult a healthcare provider before use if you have any medical conditions.

Avoid Interactions

Excedrin Migraine Relief 250 mg/1 may interact with alcohol, blood thinners, and other pain relievers. Avoid combining with other medications containing acetaminophen or aspirin. Always check with a healthcare provider before mixing with other treatments.

Frequently Asked Questions

Excedrin Migraine Relief 250 mg/1 is used for migraine pain relief, combining acetaminophen, aspirin, and caffeine to address migraine symptoms.

Store Excedrin Migraine Relief 250 mg/1 in a cool, dry place away from children and direct sunlight.

Excedrin Migraine Relief 250 mg/1 may interact with other medications, so consult a healthcare provider before combining it with other treatments.

Common effects may include drowsiness, dizziness, or upset stomach, with some users feeling more alert due to the caffeine content.

Excedrin Migraine Relief 250 mg/1 may not be suitable for everyone, especially those with allergies to its ingredients or certain medical conditions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.